Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma

•Chemotherapy is still the first-line treatment for Unresectable cholangiocarcinoma.•Targeted therapy and immunotherapy have a breakthrough in cholangiocarcinoma therapy for patients with unresectable cholangiocarcinoma.•The combination of targeted therapy and immunotherapy is superior to either single therapy or chemotherapy, which has become research interest.